Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Simcere Pharmaceutical Group Limited ( (HK:2096) ) has provided an announcement.
Simcere Pharmaceutical Group Limited has announced that its board of directors will meet on March 24, 2025, to consider and approve the annual results for the year ending December 31, 2024. The meeting will also address the potential recommendation of a final dividend, highlighting the company’s ongoing financial activities and shareholder considerations.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on developing and manufacturing pharmaceutical products, with a market presence indicated by its listing on the Hong Kong Stock Exchange under the stock code 2096.
YTD Price Performance: 10.99%
Average Trading Volume: 4,777,836
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$19.59B
For a thorough assessment of 2096 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue